The University of Chicago Header Logo

Connection

John Fung to Risk Factors

Back to Details
This is a "connection" page, showing publications John Fung has written about Risk Factors.
John Fung
Connection Strength
0.935
Risk Factors
  1. Limitations of current liver transplant immunosuppressive regimens: renal considerations. Hepatobiliary Pancreat Dis Int. 2017 Feb; 16(1):27-32.
    View in: PubMed
    Score: 0.070
  2. Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation. Transplantation. 2017 Feb; 101(2):341-349.
    View in: PubMed
    Score: 0.070
  3. The effect of Guidelines in surgical decision making: The paradigm of hepatocellular carcinoma. J BUON. 2016 Nov-Dec; 21(6):1332-1336.
    View in: PubMed
    Score: 0.069
  4. Liver transplantation for fatty liver disease. J Dig Dis. 2011 Feb; 12(1):36-7.
    View in: PubMed
    Score: 0.046
  5. Robotic versus laparoscopic resection of liver tumours. HPB (Oxford). 2010 Oct; 12(8):583-6.
    View in: PubMed
    Score: 0.045
  6. Is impaired hepatic arterial buffer response a risk factor for biliary anastomotic stricture in liver transplant recipients? Surgery. 2010 Sep; 148(3):582-8.
    View in: PubMed
    Score: 0.044
  7. Viable strategies to facilitate liver transplantation for human immunodeficiency virus coinfection. Liver Transpl. 2009 Sep; 15(9):1003-6.
    View in: PubMed
    Score: 0.042
  8. Using livers from donation after cardiac death donors--a proposal to protect the true Achilles heel. Liver Transpl. 2007 Dec; 13(12):1633-6.
    View in: PubMed
    Score: 0.037
  9. Dental health status of liver transplant candidates. Liver Transpl. 2007 Feb; 13(2):280-6.
    View in: PubMed
    Score: 0.035
  10. Preservation solutions in liver transplantation: what are the options? Liver Transpl. 2006 Feb; 12(2):196-8.
    View in: PubMed
    Score: 0.033
  11. Biliary atresia and liver transplantation in the United States: A contemporary analysis. Liver Int. 2023 10; 43(10):2198-2209.
    View in: PubMed
    Score: 0.028
  12. Real-time monitoring of acute liver-allograft rejection using the Banff schema. Transplantation. 2002 Nov 15; 74(9):1290-6.
    View in: PubMed
    Score: 0.026
  13. Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg. 2002 Oct; 236(4):429-36; discussion 436-7.
    View in: PubMed
    Score: 0.026
  14. Fungal infection in liver transplantation. Transpl Infect Dis. 2002; 4 Suppl 3:18-23.
    View in: PubMed
    Score: 0.025
  15. Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years. Liver Transpl. 2001 Jul; 7(7):623-30.
    View in: PubMed
    Score: 0.024
  16. Understanding and preventing late graft loss. Transplant Proc. 2000 Nov; 32(7):1514.
    View in: PubMed
    Score: 0.023
  17. Recipient But Not Donor Adiponectin Polymorphisms Are Associated With Early Posttransplant Hepatic Steatosis in Patients Transplanted for Non-Nonalcoholic Fatty Liver Disease Indications. Exp Clin Transplant. 2018 08; 16(4):439-445.
    View in: PubMed
    Score: 0.019
  18. International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients. Transplantation. 2018 05; 102(5):727-743.
    View in: PubMed
    Score: 0.019
  19. A new technique for hepatic parenchymal transection using an articulating bipolar 5 cm radiofrequency device: results from the first 100 procedures. HPB (Oxford). 2018 09; 20(9):829-833.
    View in: PubMed
    Score: 0.019
  20. Liver transplantation in patients with incidental hepatocellular carcinoma/cholangiocarcinoma and intrahepatic cholangiocarcinoma: a single-center experience. Hepatobiliary Pancreat Dis Int. 2017 Jun; 16(3):264-270.
    View in: PubMed
    Score: 0.018
  21. Role of donor hemodynamic trajectory in determining graft survival in liver transplantation from donation after circulatory death donors. Liver Transpl. 2016 11; 22(11):1469-1481.
    View in: PubMed
    Score: 0.017
  22. Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study. Transplantation. 2015 Jul; 99(7):1455-62.
    View in: PubMed
    Score: 0.016
  23. Prognostic role of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma undergoing liver transplantation. Liver Transpl. 2015 Jan; 21(1):101-11.
    View in: PubMed
    Score: 0.015
  24. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl. 2012 Jun; 18(6):716-26.
    View in: PubMed
    Score: 0.013
  25. Loco-regional therapy in patients with Milan Criteria-compliant hepatocellular carcinoma and short waitlist time to transplant: an outcome analysis. HPB (Oxford). 2012 May; 14(5):325-32.
    View in: PubMed
    Score: 0.013
  26. Hepatic blood flow plays an important role in ischemia-reperfusion injury. Liver Transpl. 2011 Dec; 17(12):1448-56.
    View in: PubMed
    Score: 0.012
  27. MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates. Gastroenterology. 2010 Jan; 138(1):159-64.
    View in: PubMed
    Score: 0.011
  28. Clostridium difficile colitis in patients after kidney and pancreas-kidney transplantation. Transpl Infect Dis. 2004 Mar; 6(1):10-4.
    View in: PubMed
    Score: 0.007
  29. Pancreatitis after liver transplantation in children: a single-center experience. Transplantation. 2003 Jan 27; 75(2):190-3.
    View in: PubMed
    Score: 0.007
  30. Cryptococcosis in organ transplant recipients: an overview. Am J Transplant. 2002 Aug; 2(7):575-80.
    View in: PubMed
    Score: 0.006
  31. Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis. Hepatology. 2002 Feb; 35(2):380-4.
    View in: PubMed
    Score: 0.006
  32. Influence of cold ischemia time and graft transport distance on postoperative outcome in human liver transplantation. Surg Today. 2002; 32(9):792-9.
    View in: PubMed
    Score: 0.006
  33. Ethical considerations and rationale of adult-to-adult living donor liver transplantation. Liver Transpl. 2001 Oct; 7(10):921-7.
    View in: PubMed
    Score: 0.006
  34. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 2000 Oct; 191(4):389-94.
    View in: PubMed
    Score: 0.006
  35. An analysis of pretransplantation variables associated with long-term allograft outcome in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. Transplantation. 1999 Sep 15; 68(5):650-5.
    View in: PubMed
    Score: 0.005
  36. Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 1999 Sep; 189(3):291-9.
    View in: PubMed
    Score: 0.005
  37. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg. 1998 Oct; 187(4):358-64.
    View in: PubMed
    Score: 0.005
  38. Adjuvant bone marrow infusion in clinical organ transplant recipients. Transplant Proc. 1998 Jun; 30(4):1367-8.
    View in: PubMed
    Score: 0.005
  39. Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg. 1998 May; 186(5):512-25; discussion 525-7.
    View in: PubMed
    Score: 0.005
  40. Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity. Transplantation. 1998 Feb 27; 65(4):499-504.
    View in: PubMed
    Score: 0.005
  41. Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg. 1997 Nov; 185(5):429-36.
    View in: PubMed
    Score: 0.005
  42. Cardiac operations in solid-organ transplant recipients. Ann Thorac Surg. 1997 Nov; 64(5):1270-8.
    View in: PubMed
    Score: 0.005
  43. Non-lymphoid cancer after liver transplantation. Hepatogastroenterology. 1997 Jul-Aug; 44(16):1172-81.
    View in: PubMed
    Score: 0.005
  44. Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients. Transplant Proc. 1996 Oct; 28(5):2959-65.
    View in: PubMed
    Score: 0.004
  45. Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients. Ann Surg. 1996 Jan; 223(1):70-6.
    View in: PubMed
    Score: 0.004
  46. Effect of donor age and sex on the outcome of liver transplantation. Hepatology. 1995 Dec; 22(6):1754-62.
    View in: PubMed
    Score: 0.004
  47. Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation. Transplantation. 1995 Apr 15; 59(7):1010-4.
    View in: PubMed
    Score: 0.004
  48. Acute pancreatitis after liver transplantation: incidence and contributing factors. Transpl Int. 1995; 8(1):1-7.
    View in: PubMed
    Score: 0.004
  49. Disease gravity and urgency of need as guidelines for liver allocation. Hepatology. 1994 Jul; 20(1 Pt 2):56S-62S.
    View in: PubMed
    Score: 0.004
  50. Prioritization and organ distribution for liver transplantation. JAMA. 1994 Jan 12; 271(2):140-3.
    View in: PubMed
    Score: 0.004
  51. Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet. 1993 Oct; 177(4):335-44.
    View in: PubMed
    Score: 0.003
  52. Relationship between the diagnosis, preoperative evaluation, and prognosis after orthotopic liver transplantation. Ann Surg. 1988 Aug; 208(2):196-202.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.